Jeffery Diberto
Director of Assay Development and co-founder at EvE Bio
Key Impact
He is a key experimental pharmacology researcher in psychedelic science, contributing to landmark work on 5-HT2A receptor structure, engineered mouse models, and receptor-docking studies linked to antidepressant effects.
Background & Research
Jeffery DiBerto is a former graduate researcher in Bryan Roth’s lab at the University of North Carolina at Chapel Hill, where he studied GPCR pharmacology with a focus on opioid and serotonin receptors. He co-authored multiple influential papers in Cell, Nature, and Nature Communications on psychedelic drug action, 5-HT2A receptor biology, and related therapeutic mechanisms. He is now listed as Director of Assay Development and co-founder at EvE Bio.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →